bioAffinity Technologies (BIAF) Inventory Average (2022 - 2026)

bioAffinity Technologies has disclosed Inventory Average across 5 years of filings, most recently posting $65717.5 for Q1 2026.

• In Q1 2026, Inventory Average rose 97.97% year-over-year to $65717.5; the TTM figure through Mar 2026 stood at $65717.5 (up 97.97% YoY), while the FY2025 annual figure was $40578.0, up 76.07% from the prior year.
• Inventory Average grew to $65717.5 in Q1 2026, from $44391.0 in the prior quarter.
• Over the last five years, Inventory Average for BIAF reached as high as $65717.5 in Q1 2026 and fell as low as $5627.5 in Q4 2022.
• The 5-year median for Inventory Average is $23056.5 (2024), against an average of $25780.7.
• Annual changes were most pronounced in 2024 — Inventory Average soared 175.53% — and 2025, when it soared 43.67%.
• A 5-year view of Inventory Average shows it stood at $5627.5 in 2022, then soared by 152.26% to $14196.0 in 2023, then jumped by 86.57% to $26485.5 in 2024, then surged by 67.6% to $44391.0 in 2025, then jumped by 48.04% to $65717.5 in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $65717.5, $44391.0, and $39602.5 for Q1 2026, Q4 2025, and Q3 2025 respectively.